DSpace@İnönü
Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy)
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Cumurcu, Tongabay | |
| dc.contributor.author | Cumurcu, Birgül Elbozan | |
| dc.contributor.author | Zayman, Esra Porgalı | |
| dc.contributor.author | Çavdar, Müfide | |
| dc.contributor.author | Nurlu, Kayhan | |
| dc.contributor.author | Doğanay, Selim | |
| dc.date.accessioned | 2020-05-27T18:15:01Z | |
| dc.date.available | 2020-05-27T18:15:01Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | Tongabay C., Birgül ELBOZAN C., Esra PORGALI Z., Müfide Ç., Kayhan N., Selim D. (2017). Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy), Retina-Vitreus, İnönü Üniversitesi, Malatya. | tr_TR |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/15598 | |
| dc.description | Öz:A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe):Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe): | tr_TR |
| dc.description.abstract | Öz:A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe):Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe): | tr_TR |
| dc.language.iso | tr | tr_TR |
| dc.publisher | Retina-Vitreus | tr_TR |
| dc.subject | Göz Hastalıkları | tr_TR |
| dc.title | Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy) | tr_TR |
| dc.title.alternative | Muhtemel Sertraline Bağlı Santral Seroz Retinopati | tr_TR |
| dc.type | Article | tr_TR |
